Toxicity from radiation therapy associated with abnormal transcriptional responses to DNA damage.

Toxicity from radiation therapy is a grave problem for cancer patients. We hypothesized that some cases of toxicity are associated with abnormal transcriptional responses to radiation. We used microarrays to measure responses to ionizing and UV radiation in lymphoblastoid cells derived from 14 patients with acute radiation toxicity. The analysis used heterogeneity-associated transformation of the data to account for a clinical outcome arising from more than one underlying cause. To compute the risk of toxicity for each patient, we applied nearest shrunken centroids, a method that identifies and cross-validates predictive genes. Transcriptional responses in 24 genes predicted radiation toxicity in 9 of 14 patients with no false positives among 43 controls (P = 2.2 x 10(-7)). The responses of these nine patients displayed significant heterogeneity. Of the five patients with toxicity and normal responses, two were treated with protocols that proved to be highly toxic. These results may enable physicians to predict toxicity and tailor treatment for individual patients.

[1]  C. Perez,et al.  Principles and Practice of Radiation Oncology , 1987 .

[2]  F. Holmes,et al.  Consequences of breast irradiation in patients with pre-existing collagen vascular diseases. , 1989, International journal of radiation oncology, biology, physics.

[3]  R. Matter,et al.  Breast conservation therapy. Severe breast fibrosis after radiation therapy in patients with collagen vascular disease , 1991, Cancer.

[4]  S. West,et al.  Biological roles of the Escherichia coli RuvA, RuvB and RuvC proteins revealed , 1992, Molecular microbiology.

[5]  M. Morange,et al.  Ubiquitin pathway involvement in human lymphocyte gamma-irradiation-induced apoptosis , 1993, Molecular and cellular biology.

[6]  C. Lange-Carter,et al.  A divergence in the MAP kinase regulatory network defined by MEK kinase and Raf , 1993, Science.

[7]  M. Källberg,et al.  Determination of urinary 8-hydroxydeoxyguanosine by automated coupled-column high performance liquid chromatography: a powerful technique for assaying in vivo oxidative DNA damage in cancer patients. , 1995, European journal of cancer.

[8]  R. Cowan,et al.  A comparison of the radiosensitivity of lymphocytes from normal donors, cancer patients, individuals with ataxia-telangiectasia (A-T) and A-T heterozygotes. , 1995, International journal of radiation biology.

[9]  M. Lovett,et al.  A single ataxia telangiectasia gene with a product similar to PI-3 kinase. , 1995, Science.

[10]  J Nyman,et al.  Prognostic factors for acute and late skin reactions in radiotherapy patients. , 1996, International journal of radiation oncology, biology, physics.

[11]  S M Bentzen,et al.  Relationship between the in vitro radiosensitivity of skin fibroblasts and the expression of subcutaneous fibrosis, telangiectasia, and skin erythema after radiotherapy. , 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[12]  P. Kellokumpu-Lehtinen,et al.  Biomarker evidence of DNA oxidation in lung cancer patients: association of urinary 8‐hydroxy‐2′‐deoxyguanosine excretion with radiotherapy, chemotherapy, and response to treatment , 1997, FEBS letters.

[13]  Matthias Platzer,et al.  Nibrin, a Novel DNA Double-Strand Break Repair Protein, Is Mutated in Nijmegen Breakage Syndrome , 1998, Cell.

[14]  M. Lavin,et al.  Testing for mutations of the ataxia telangiectasia gene in radiosensitive breast cancer patients. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[15]  A. Hart,et al.  Low predictive value of intrinsic fibroblast radiosensitivity for fibrosis development following radiotherapy for breast cancer. , 1998, International journal of radiation biology.

[16]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Overexpression of AML1 renders a T hybridoma resistant to T cell receptor-mediated apoptosis , 1998, Oncogene.

[18]  D. Brenner,et al.  A preliminary report: frequency of A-T heterozygotes among prostate cancer patients with severe late responses to radiation therapy. , 1998, The cancer journal from Scientific American.

[19]  H. Blattmann,et al.  Altered apoptotic profiles in irradiated patients with increased toxicity. , 1999, International journal of radiation oncology, biology, physics.

[20]  T. Stankovic,et al.  The DNA Double-Strand Break Repair Gene hMRE11 Is Mutated in Individuals with an Ataxia-Telangiectasia-like Disorder , 1999, Cell.

[21]  A. Rosenthal,et al.  Sequence analysis of the ATM gene in 20 patients with RTOG grade 3 or 4 acute and/or late tissue radiation side effects. , 1999, International journal of radiation oncology, biology, physics.

[22]  J. Yarnold,et al.  Cellular radiosensitivity and complication risk after curative radiotherapy. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[23]  G. Woloschak,et al.  Modulation of calmodulin by UV and X-rays in primary human endothelial cell cultures. , 2000, International journal of radiation biology.

[24]  D. Kondziolka,et al.  Development of a model to predict permanent symptomatic postradiosurgery injury for arteriovenous malformation patients. Arteriovenous Malformation Radiosurgery Study Group. , 2000, International journal of radiation oncology, biology, physics.

[25]  A. Kiltie,et al.  Relationship between in vitro chromosomal radiosensitivity of peripheral blood lymphocytes and the expression of normal tissue damage following radiotherapy for breast cancer. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[26]  C. Badie,et al.  Repression of CDK1 and Other Genes with CDE and CHR Promoter Elements during DNA Damage-Induced G2/M Arrest in Human Cells , 2000, Molecular and Cellular Biology.

[27]  B. Lopez,et al.  Human 100-kDa homologous DNA-pairing protein is the splicing factor PSF and promotes DNA strand invasion. , 2000, Nucleic acids research.

[28]  D. Andrews,et al.  Bcl-2 and Bax regulate the channel activity of the mitochondrial adenine nucleotide translocator , 2000, Oncogene.

[29]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[30]  I. Näslund,et al.  Can 8-oxo-dG be used as a predictor for individual radiosensitivity? , 2001, International journal of radiation oncology, biology, physics.

[31]  A. Fischer,et al.  Artemis, a Novel DNA Double-Strand Break Repair/V(D)J Recombination Protein, Is Mutated in Human Severe Combined Immune Deficiency , 2001, Cell.

[32]  J. Ninomiya-Tsuji,et al.  Regulation of the TAK1 Signaling Pathway by Protein Phosphatase 2C* , 2001, The Journal of Biological Chemistry.

[33]  Maria Cristina C Gomes-Marcondes,et al.  Induction of protein catabolism and the ubiquitin-proteasome pathway by mild oxidative stress. , 2002, Cancer letters.

[34]  Geoffrey J McLachlan,et al.  Selection bias in gene extraction on the basis of microarray gene-expression data , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[35]  R. Tibshirani,et al.  Diagnosis of multiple cancer types by shrunken centroids of gene expression , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[36]  J. Loeffler,et al.  The effect of nonmalignant systemic disease on tolerance to radiation therapy. , 2002, The oncologist.

[37]  G. Kroemer,et al.  The adenine nucleotide translocator in apoptosis. , 2002, Biochimie.

[38]  Trevor Hastie,et al.  Class Prediction by Nearest Shrunken Centroids, with Applications to DNA Microarrays , 2003 .

[39]  S. Loft,et al.  Cancer risk and oxidative DNA damage in man , 1996, Journal of Molecular Medicine.